Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of TWST is 48 and suggests 13% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
Buy
Sell